Skip to main content

2 Result(s)

within Hema Mistry Remove this filter Health Administration Remove this filter Health Economics Remove this filter

and
Your search also matched 2 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you. results, e.g.

Autologous Chondrocyte Implantation with Chondrosphere for Treating Articular Cartilage Defects in the Knee: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Include preview-only content

  1. Article

    Open Access

    Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

    Open Access This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/

    Hema Mistry, Chidozie Nduka, Martin Connock, Jill Colquitt… in PharmacoEconomics (2019)

    Download PDF (498 KB) View Article

  2. Article

    Open Access

    Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

    Venetoclax is licensed to treat relapsed or refractory (R/R) chronic lymphocytic leukaemia (CLL). As part of the Single Technology Appraisal (STA) ID944, the National Institute for Health and Care Excellence (...

    Hema Mistry, Chidozie Nduka, Martin Connock, Jill Colquitt… in PharmacoEconomics (2018)

    Download PDF (515 KB) View Article